ArticleCureus2025
Benign Hypertrophied Column of Bertin Mimicking a Renal Tumor in a Child: A Diagnostic Challenge.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The hypertrophied column of Bertin (HCB) is a benign anatomical variant of the renal cortex that may mimic a neoplastic mass, particularly on ultrasound, potentially leading to unnecessary diagnostic or surgical interventions. We report the case of a nine-year-old girl in whom a renal lesion was incidentally discovered during follow-up imaging for a post-traumatic subcapsular hematoma. Renal ultrasound revealed an isoechoic mass in the mid-portion of the left kidney, extending into the renal sinus. Color Doppler demonstrated a vascular pattern similar to the adjacent parenchyma. Contrast-enhanced computed tomography (CT) confirmed the diagnosis of HCB based on key imaging features, including homogeneity, isoattenuation relative to the renal cortex, and preservation of normal renal architecture. No signs of necrosis, distortion, or abnormal enhancement were observed. This case highlights the importance of recognizing the characteristic imaging features of HCB to prevent misdiagnosis and avoid unnecessary intervention. In asymptomatic patients, conservative management with imaging follow-up is an appropriate and safe approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.